Dr. Andrew Zolopa, MD is a Internal Medicine Physician - Infectious Disease practicing in Stanford, CA
He has not yet shared a personalized biography with Doctor.com.
| Institution | Focus | Year |
|---|---|---|
| Internship - Santa Clara Vly Medical Ctr | Not Specified |
| Certification | Cert. Body | Year |
|---|---|---|
| Internal medicine | Internal Medicine | Not Specified |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | Clinical infectious diseases | Low Baseline CD4+ Count Is Associated With Greater Bone Mineral Density Loss After Antiretroviral | 2013 |
| Other Publication | JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | A Randomized Double-Blind Comparison of Coformulated | 2013 |
| Other Publication | AIDS | Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS | 2013 |
| Other Publication | JOURL OF GENE MEDICINE | Patient monitoring and follow-up in lentiviral clinical trials | 2013 |
| Other Publication | JOURL OF INFECTIOUS DISEASES | Elevated Interleukin 8 and T-Helper 1 and T | 2012 |
| Other Publication | Current HIV/AIDS reports | When to start ART in the setting of acute AIDS-related opportunistic infections: the time is now! | 2012 |
| Other Publication | LANCET | Co-formulated elvitegravir | 2012 |
| Other Publication | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | Standardized Comparison of the Relative Impacts of HIV-1 Reverse Transcriptase | 2012 |
| Other Publication | PLOS ONE | Association of Low Level Viremia with Inflammation and Mortality in HIV-Infected Adults | 2011 |
| Other Publication | CLINICAL INFECTIOUS DISEASES | Blood (1 -> 3)-beta-D-Glucan as a Diagnostic Test for HIV-Related Pneumocystis jirovecii Pneumonia | 2011 |
| Other Publication | AIDS | Cost-effectiveness of antiretroviral regimens in the World Health Organization's treatment | 2011 |
| Other Publication | JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | Inflammation and Mortality in HIV-Infected Adults: Alysis of the FRAM Study Cohort | 2010 |
| Other Publication | CLINICAL INFECTIOUS DISEASES | Concerns Regarding a R | 2010 |
| Other Publication | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance | 2010 |
| Other Publication | HIV CLINICAL TRIALS | Early Antiretroviral Therapy for Patients With Acute AIDS-Related Opportunistic Infections | 2010 |
| Other Publication | CURRENT OPINION IN INVESTIGATIOL DRUGS | Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance | 2010 |
| Other Publication | PLOS ONE | Risk Factor Alyses for Immune Reconstitution Inflammatory Syndrome in a R | 2010 |
| Other Publication | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | Predicting Tipravir and Daruvir Resistance Using Genotypic, Phenotypic | 2010 |
| Other Publication | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | Intertiol Cohort Alysis of the Antiviral Activities of Zidovudine | 2010 |
| Other Publication | JOURL OF INFECTIOUS DISEASES | Activity of Elvitegravir, a Once-Daily Integrase Inhibitor | 2010 |
| Other Publication | AIDS | Development of a didanosene genotypic resistance interpretation system based on large derivation | 2010 |
| Other Publication | JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | Association of HIV Infection | 2010 |
| Other Publication | ANTIVIRAL RESEARCH | The evolution of HIV treatment guidelines: Current state-of-the-art of ART | 2010 |
| Other Publication | JOURL OF CLINICAL VIROLOGY | Switch from enfuvirtide to raltegravir in virologically suppressed HIV-1 infected patients | 2009 |
| Other Publication | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease | 2009 |
| Other Publication | CURRENT OPINION IN HIV AND AIDS | The use of resistance testing in the magement of HIV-1-infected patients | 2009 |
| Other Publication | PLOS ONE | Early Antiretroviral Therapy Reduces AIDS Progression | 2009 |
| Other Publication | Current HIV/AIDS reports | Initiation of antiretroviral therapy in the hospitalized patient with an acute AIDS | 2009 |
| Other Publication | CLINICAL INFECTIOUS DISEASES | Maintaining Reduced Viral Fitness | 2009 |
| Other Publication | JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | Hepatotoxicity and Gastrointestil Intolerance When Healthy Volunteers Taking Rifampin Add Twice | 2009 |
| Other Publication | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | Safety and Efficacy of Enfuvirtide in Combition with Daruvir | 2008 |
| Other Publication | AMERICAN JOURL OF CLINICAL NUTRITION | Evaluation of high-protein supplementation in weight | 2008 |
| Other Publication | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | Virologic Response to Lopivir-Ritovir | 2008 |
| Other Publication | JOURL OF INFECTIOUS DISEASES | Initiatives for developing and comparing genotype interpretation systems | 2008 |
| Other Publication | Jourl of HIV therapy | Integrase inhibitors: a clinical review of raltegravir and elvitegravir. | 2008 |
| Other Publication | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | Effect of concomitantly administered rifampin on the pharmacokinetics | 2007 |
| Other Publication | JOURL OF INFECTIOUS DISEASES | Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor | 2007 |
| Other Publication | JOURL OF INFECTIOUS DISEASES | A randomized, partially blinded phase 2 trial of antiretroviral therapy | 2006 |
| Other Publication | AIDS RESEARCH AND HUMAN RETROVIRUSES | N88D facilitates the co | 2006 |
| Other Publication | JOURL OF INFECTIOUS DISEASES | Incorporating drug-resistance measurements into the clinical magement of HIV-1 infection | 2006 |
| Other Publication | AMERICAN JOURL OF EPIDEMIOLOGY | The study of fat redistribution and metabolic change in HIV infection (FRAM): Methods, design | 2006 |
| Other Publication | QUALITY OF LIFE RESEARCH | The effect of diagnosis with HIV infection on health-related quality of life | 2006 |
| Other Publication | MedGenMed : Medscape general medicine | Case files from Stanford University Medical Center | 2006 |
| Other Publication | CLINICAL PHARMACOLOGY & THERAPEUTICS | Pharmacokinetic interactions between indivir plus ritovir and calcium channel blockers | 2005 |
| Other Publication | JOURL OF INFECTIOUS DISEASES | HIV-1 protease and reverse-transcriptase mutations | 2005 |
| Other Publication | CLINICAL INFECTIOUS DISEASES | Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection | 2005 |
| Other Publication | CLINICAL INFECTIOUS DISEASES | Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation | 2005 |
| Other Publication | JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | Detection of minority populations of HIV | 2005 |
| Other Publication | INTERTIOL JOURL OF STD & AIDS | Prevalence of antiretroviral drug resistance in the HIV-1 | 2004 |
| Other Publication | ANTIVIRAL THERAPY | Clinically validated genotype alysis: guiding principles and statistical concerns | 2004 |
| Other Publication | AIDS | High levels of adherence do not prevent accumulation of HIV drug resistance mutations | 2003 |
| Other Publication | JOURL OF INFECTIOUS DISEASES | Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person | 2003 |
| Other Publication | AIDS | Extended spectrum of HIV | 2003 |
| Other Publication | JOURL OF VIROLOGY | Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease | 2003 |
| Other Publication | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | Virtual inhibitory quotient predicts response to ritovir boosting of indivir | 2002 |
| Other Publication | JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to | 2002 |
| Other Publication | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | Evolution of primary protease inhibitor resistance mutations during protease inhibitor salvage | 2002 |
| Other Publication | JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | Characterization of the HIV | 2001 |
| Other Publication | AIDS clinical care | HIV drug resistance testing: an update for the clinician. | 2001 |
| Other Publication | JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | Genotypic correlates of a virologic response to stavudine after zidovudine monotherapy | 2001 |
| Other Publication | AIDS | Non-adherence to highly active antiretroviral therapy predicts progression to AIDS | 2001 |
| Other Publication | AIDS | Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment | 2001 |
| Other Publication | JOURL OF CLINICAL MICROBIOLOGY | High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease | 2001 |
| Other Publication | AIDS RESEARCH AND HUMAN RETROVIRUSES | Highly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes | 2000 |
| Other Publication | ARCHIVES OF INTERL MEDICINE | Adherence to isoniazid prophylaxis in the homeless - A randomized controlled trial | 2000 |
| Other Publication | AIDS | Adherence to protease inhibitors, HIV-1 viral load | 2000 |
| Other Publication | ANTIVIRAL THERAPY | The relation between baseline HIV drug resistance and response to antiretroviral therapy | 2000 |
| Other Publication | JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients | 2000 |
| Other Publication | ANLS OF INTERL MEDICINE | HIV-1 genotypic resistance patterns predict response to saquivir | 1999 |
| Other Publication | CLINICAL INFECTIOUS DISEASES | Invasive fungal sinusitis due to Scedosporium apiospermum in a patient with AIDS | 1999 |
| Other Publication | Lawrence, J., Schapiro, J., Winters, M., Montoya, J., Zolopa, A., Pesa | Clinical resistance patterns | 1999 |
| Other Publication | JOURL OF COMMUNITY HEALTH | Association between time homeless and perceived health status among the homeless in San Francisco | 1997 |
| Other Publication | AIDS | PREVALENCE OF MEASLES ANTIBODIES IN ADULTS WITH HIV-INFECTION | 1992 |
Years In Practice: 20 (started in 2005)
Accepts New Patients: Yes
Dr. Andrew Zolopa, MD has not yet listed the medications that he commonly prescribes.
